Neurodegenerative disorders are primarily characterized by neuron loss. The most common
neurodegenerative disorders include Alzheimer's and Parkinson's disease. Although there …

Parkinson's disease (PD) is the second leading neurodegenerative disease globally,
impacting the quality of life of millions of people. It is estimated that the treatment cost of PD …

Intravenous delivery of nanomaterials containing therapeutic agents and various cargos for
treating neurological disorders is often constrained by low delivery efficacy due to difficulties …

The development of biohydrogen as an alternative energy source has had great economic
and environmental benefits. Hydrogen production from microalgae is considered a clean …

Rotigotine (RTG) is a non-ergoline dopamine agonist and an approved drug for treating
Parkinson's disease. However, its clinical use is limited due to various problems, viz. poor …

Dementia, most often associated with neurodegenerative diseases, affects millions of
people worldwide, predominantly the elderly. Unfortunately, no treatment is still available …

Neurological disorders have become severe and dreadful issues around the globe that are
rarely directly mediated because of the blood-brain barrier (BBB). Despite the various …

Algal biorefinery is rising as a prominent solution to economically fulfill the escalating global
requirement for nutrition, feed, fuel, and medicines. In recent years, scientific productiveness …

Rivastigmine hydrogen tartrate (RIV-HT) is given orally for Alzheimer's disease. However,
oral therapy shows low brain bioavailability, short half-life and gastrointestinal-mediated …

Neurodegenerative diseases (NDs) are progressive disorders that cause the degeneration
of neurons. Mitochondrial dysfunction is a common symptom in NDs and plays a crucial role …